Effect of Zinc Suplementation on Serum Hemosystein Level in Hemodialysis Patients

NCT01101217 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2010-04-09

No results posted yet for this study

Summary

The purpose of this study is to study the effect of zinc supplementation in end stage renal failure on hemocystein level.

Conditions

  • End Stage Renal Failure

Interventions

DRUG

Zinc Supplement

in 50 patients zinc sulfate 220 mg per day orally for 6 weeks

DRUG

placebo

placebo daily for 6 weeks

Sponsors & Collaborators

  • Shiraz University of Medical Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Completion
2009-09-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01101217 on ClinicalTrials.gov